Synjardy 12.5 mg/1 (Empagliflozin and Metformin Hydrochloride TABLET) 12.5 mg/1

Synjardy 12.5 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Strength

12.5 mg/1

Pack Size

60 TABLET in 1 BOTTLE (0597-0168-60)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy 12.5 mg/1 tablets are used to help manage type 2 diabetes in adults. This combination medication works by improving blood sugar control, often used alongside diet and exercise. People may ask, 'What is Synjardy used for?' primarily to support glycemic management.

Side Effects

Common effects of Synjardy 12.5 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users experience mild dizziness or headache. Individual responses can vary, and not everyone will encounter these effects.

Precautions & Warnings

Handle Synjardy 12.5 mg/1 tablets with care, especially if you have kidney issues or are dehydrated. Always follow your healthcare provider's advice regarding usage. Store in a cool, dry place away from children.

Avoid Interactions

Synjardy 12.5 mg/1 tablets may interact with certain medications, including diuretics and other diabetes treatments. Alcohol can also affect how this medication works. Discuss all current medications with your healthcare provider before starting Synjardy.

Frequently Asked Questions

Synjardy 12.5 mg/1 tablets are used to help manage type 2 diabetes by improving blood sugar control.

Store Synjardy 12.5 mg/1 tablets in a cool, dry place, away from children and direct sunlight.

Synjardy 12.5 mg/1 tablets may interact with other medications, so consult your healthcare provider before combining.

Common side effects may include urinary tract infections, nausea, and diarrhea.

Synjardy 12.5 mg/1 tablets are not suitable for everyone, especially those with severe kidney issues or dehydration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.